5P Hormonal biomarkers can improve prediction of response to hormonal therapy in advanced and recurrent endometrial cancer: Results of the PROMOTE-R study

Authors :: A. van de Stolpe
H. J. van Beekhuizen
A. Van Ginkel
L. Van Lonckhuijzen
Kristina Lindemann
J.M.A. Pijnenborg
David Forsse
Camilla Krakstad
Johan Bulten
R. Yigit
Márcia Alves De Inda
Vít Weinberger
D. Boll
Roy I. Lalisang
Khadra Galaal
E. Witteveen
WJ van Weelden
Hmj Werner
Hans Trum
Andrea Romano
Source :: Annals of Oncology. 31:S1218
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
medicine
Hormonal therapy
Hematology
business
Recurrent Endometrial Cancer
Hormone

Full Text Access

Tools